Results 91 to 100 of about 339,620 (340)
Background: Soluble transferrin receptor (sTfR) is a biomarker of erythropoiesis, which is often impaired in dialysis patients. The aim of our study was to evaluate sTfR levels in chronically dialyzed patients and assess potential determinants of its ...
Luís Belo +12 more
doaj +1 more source
Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients [PDF]
Saeid Amirkhanlou +4 more
openalex +1 more source
ABSTRACT Introduction Synchronous bilateral renal cell carcinoma is a rare clinical entity that poses considerable challenges in establishing an optimal treatment strategy. Case Presentation A 56‐year‐old woman had synchronous bilateral renal cell carcinoma, with tumors in the right (61 mm) and left (71 mm) kidneys.
Hiroki Kawabata +6 more
wiley +1 more source
BackgroundABO-incompatible kidney transplantation (ABOi-KTx) represents a possible solution to address the shortage of kidney donors. However, these transplants present immunological challenges, particularly when isoagglutinin titers are elevated ...
Hamza Naciri Bennani +7 more
doaj +1 more source
ABSTRACT Introduction Lenvatinib (LEN) concentrations in patients undergoing hemodialysis (HD) have not been examined. Herein, we report the effect of HD on total and free LEN concentrations in a patient with mRCC. Case Presentation The hemodialyzed patient was a 55‐year‐old Japanese male who was treated with 20 mg LEN daily.
Takahiro Ito +5 more
wiley +1 more source
POS-700 PREGNANCY IN KIDNEY TRANSPLANT RECIPIENTS: EFFECTS ON MOTHER AND CHILD
M. MOJAAT +8 more
doaj +1 more source
Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context.
Dominique Bertrand +12 more
doaj +1 more source
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai +8 more
wiley +1 more source
POS-698 VARICELLA ZOSTER VIRUS IN TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY
M. MOJAAT +8 more
doaj +1 more source
Augmented Cardiopulmonary Baroreflex Sensitivity in Intradialytic Hypertension. [PDF]
IntroductionEnd-stage renal disease (ESRD) patients with a paradoxical increase in blood pressure (BP) during hemodialysis (HD), termed intradialytic hypertension (ID-HTN), are at significantly increased risk for mortality and adverse cardiovascular ...
DaCosta, Dana R +5 more
core

